JW Shinyak Corporation (KOSDAQ:067290)
South Korea
· Delayed Price · Currency is KRW 2,070.00
-10.00 (-0.48%)
At close: Apr 28, 2026
JW Shinyak Revenue
In the year 2025, JW Shinyak had annual revenue of 81.04B KRW, down -12.87%. JW Shinyak had revenue of 21.10B in the quarter ending December 31, 2025, with 31.22% growth.
Revenue
81.04B
Revenue Growth
-12.87%
P/S Ratio
1.41
Revenue / Employee
442.86M
Employees
183
Market Cap
114.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.04B | -11.97B | -12.87% |
| Dec 31, 2024 | 93.01B | -11.22B | -10.77% |
| Dec 31, 2023 | 104.23B | 1.52B | 1.48% |
| Dec 31, 2022 | 102.71B | 1.74B | 1.73% |
| Dec 31, 2021 | 100.97B | -2.84B | -2.73% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sewoon Medical | 63.66B |
| OSTEONIC | 45.39B |
| SCL Science | 22.01B |
| CG MedTech | 47.23B |
| Wonbiogen | 35.24B |
| DuChemBIO | 38.57B |
| KM Corporation | 135.41B |
| MEDYSSEY Co.,Ltd | 10.60B |